Precision Oncology Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Precision Oncology Market Report 2026

Name: Precision Oncology Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (Genomic Sequencing, Immunotherapy), By Test Type (Genetic Tests, Biomarker-Based Tests, Therapeutics), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Skin Cancer, Stomach Cancer, Other Cancers), By Technology (Next-Generation Sequencing, Bioinformatics, Molecular Imaging, Liquid Biopsy), By End-users (Hospitals, Research Laboratories, Pharmaceutical Companies, Diagnostic Centers) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Precision Oncology Market Overview

• Precision Oncology market size has reached to $106.21 billion in 2025

• Expected to grow to $175.38 billion in 2030 at a compound annual growth rate (CAGR) of 10.5%

• Growth Driver: Rising Adoption Of Personalized Therapies Driving The Market Growth Due To Advances In Genomic Technologies And Targeted Treatment Approaches

• Market Trend: Advancing Personalized Cancer Care Through Genomic-Driven Innovations

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Precision Oncology Market?

Precision oncology refers to a medical approach that tailors cancer treatment to the individual characteristics of each patient. This involves using molecular and genetic profiling of tumors to identify specific mutations, biomarkers, or pathways driving cancer growth, allowing clinicians to select targeted therapies that are more likely to be effective and less harmful than traditional treatments.

The main types of precision oncology include genomic sequencing and immunotherapy. Genomic sequencing is the process of determining the complete DNA sequence of an organism's genome at a single time. Product offerings in this field include genetic tests, biomarker-based tests, and targeted therapeutics, which are used in the treatment of various cancers, such as breast, lung, colorectal, prostate, skin, stomach, and others. Supporting technologies include next-generation sequencing, bioinformatics, molecular imaging, and liquid biopsy. The primary end users comprise hospitals, research laboratories, pharmaceutical companies, and diagnostic centers.

Precision Oncology Market Global Report 2026 Market Report bar graph

What Is The Precision Oncology Market Size and Share 2026?

The precision oncology market size has grown rapidly in recent years. It will grow from $106.21 billion in 2025 to $117.67 billion in 2026 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to limited availability of genomic sequencing technologies, reliance on conventional chemotherapy, increasing cancer prevalence globally, early adoption of immunotherapy, growing research in molecular oncology.

What Is The Precision Oncology Market Growth Forecast?

The precision oncology market size is expected to see rapid growth in the next few years. It will grow to $175.38 billion in 2030 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to development of next-generation sequencing platforms, increasing integration of bioinformatics and AI in oncology, rising adoption of liquid biopsy and molecular imaging, expansion of personalized treatment options, growth of research collaborations between hospitals and pharmaceutical companies. Major trends in the forecast period include expansion of targeted cancer therapies based on molecular profiling, increasing adoption of liquid biopsy and non-invasive diagnostic methods, growth in biomarker-based testing for personalized treatment plans, rising integration of immunotherapy with genomic sequencing, enhanced focus on rare and hard-to-treat cancer types.

Book your 30 minutes free consultation with our research experts

Global Precision Oncology Market Segmentation

1) By Type: Genomic Sequencing, Immunotherapy

2) By Test Type: Genetic Tests, Biomarker-Based Tests, Therapeutics

3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Skin Cancer, Stomach Cancer, Other Cancers

4) By Technology: Next-Generation Sequencing, Bioinformatics, Molecular Imaging, Liquid Biopsy

5) By End-users: Hospitals, Research Laboratories, Pharmaceutical Companies, Diagnostic Centers

Subsegments:

1) By Genomic Sequencing: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing

2) By Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines, Adoptive Cell Therapy

What Is The Driver Of The Precision Oncology Market?

The increasing awareness and shift towards personalized therapies are expected to propel the growth of the precision oncology market going forward. Personalized therapies are treatments customized to an individual's genetic makeup, biomarkers, and specific disease characteristics to enhance effectiveness and reduce side effects. Personalized therapies are increasing due to advancements in genomic technologies that enable the precise identification of disease-driving mutations, allowing for more effective and targeted treatments. Precision oncology helps advance personalized therapies by using genomic and molecular profiling to tailor cancer treatment to the specific genetic makeup of a patient's tumor. For instance, in February 2023, according to GOV.UK, a UK-based government department, Health and Social Care Secretary signed an MoU with BioNTech SE to advance cancer vaccine research in England, aiming to deliver 10,000 personalized therapy doses to UK patients by 2030. Therefore, the increasing awareness and shift towards personalized therapies are driving the growth of the precision oncology industry.

Key Players In The Global Precision Oncology Market

Major companies operating in the precision oncology market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., AstraZeneca plc., Novartis AG, Amgen Inc., Agilent Technologies Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, NeoGenomics Laboratories Inc., Myriad Genetics Inc., Invitae Corporation, Caris Life Sciences, Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Strata Oncology Inc.

Global Precision Oncology Market Trends and Insights

Major companies operating in the precision oncology market are focusing on developing innovative approaches, such as the molecular tumor board, to support personalized treatment decisions by integrating genomic information with clinical context. A molecular tumor board refers to a dedicated panel of specialists that analyzes and interprets complex genomic and molecular test data to inform precision-driven cancer therapies tailored to the specific tumor characteristics of individual patients. For instance, in December 2024, Aster DM Healthcare Ltd., a UAE-based healthcare provider, introduced a precision oncology clinic as part of three personalized cancer care initiatives designed to transform treatment through data-driven, genomic-focused strategies. This clinic delivers customized cancer therapy based on each patient’s tumor genetic profile, enabling more precise, effective treatments with reduced side effects. The approach enhances treatment outcomes, minimizes toxicity, and improves quality of life by aligning therapies to the unique molecular features of a patient's cancer.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Precision Oncology Market?

In March 2024, Bayer AG, a Germany-based pharmaceutical company, partnered with Aignostics GmbH to advance precision oncology by utilizing Aignostics' AI-powered computational pathology and patient data to support the discovery and development of more effective cancer treatments. Aignostics GmbH is a Germany-based artificial intelligence (AI) company that offers technologies tailored for precision oncology.

Regional Insights

North America was the largest region in the precision oncology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Precision Oncology Market?

The precision oncology market consists of revenues earned by entities by providing services such as genomic and molecular profiling services, companion diagnostics services, and personalized treatment planning. The market value includes the value of related goods sold by the service provider or included within the service offering. The precision oncology market also includes sales of genomic and molecular diagnostic equipment, immune checkpoint inhibitors, and bioinformatics and decision support tools. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Precision Oncology Market Report 2026?

The precision oncology market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the precision oncology industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Precision Oncology Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$117.67 billion
Revenue Forecast In 2035	$175.38 billion
Growth Rate	CAGR of 10.8% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Test Type, Cancer Type, Technology, End-users
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., AstraZeneca plc., Novartis AG, Amgen Inc., Agilent Technologies Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, NeoGenomics Laboratories Inc., Myriad Genetics Inc., Invi
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Precision Oncology Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Precision Oncology Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Precision Oncology Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Precision Oncology Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Expansion Of Targeted Cancer Therapies Based On Molecular Profiling

4.2.2 Increasing Adoption Of Liquid Biopsy And Non-Invasive Diagnostic Methods

4.2.3 Growth In Biomarker-Based Testing For Personalized Treatment Plans

4.2.4 Rising Integration Of Immunotherapy With Genomic Sequencing

4.2.5 Enhanced Focus On Rare And Hard-To-Treat Cancer Types

5. Precision Oncology Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Research Laboratories

5.3 Pharmaceutical Companies

5.4 Diagnostic Centers

5.5 Oncology Specialty Clinics

6. Precision Oncology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Precision Oncology Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Precision Oncology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Precision Oncology Market Size, Comparisons And Growth Rate Analysis

7.3. Global Precision Oncology Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Precision Oncology Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Precision Oncology Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Precision Oncology Market Segmentation

9.1. Global Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Genomic Sequencing, Immunotherapy

9.2. Global Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Genetic Tests, Biomarker-Based Tests, Therapeutics

9.3. Global Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Skin Cancer, Stomach Cancer, Other Cancers

9.4. Global Precision Oncology Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Next-Generation Sequencing, Bioinformatics, Molecular Imaging, Liquid Biopsy

9.5. Global Precision Oncology Market, Segmentation By End-users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Research Laboratories, Pharmaceutical Companies, Diagnostic Centers

9.6. Global Precision Oncology Market, Sub-Segmentation Of Genomic Sequencing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing

9.7. Global Precision Oncology Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Immune Checkpoint Inhibitors, Cancer Vaccines, Adoptive Cell Therapy

10. Precision Oncology Market Regional And Country Analysis

10.1. Global Precision Oncology Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Precision Oncology Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Precision Oncology Market

11.1. Asia-Pacific Precision Oncology Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Precision Oncology Market

12.1. China Precision Oncology Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Precision Oncology Market

13.1. India Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Precision Oncology Market

14.1. Japan Precision Oncology Market Overview

14.2. Japan Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Precision Oncology Market

15.1. Australia Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Precision Oncology Market

16.1. Indonesia Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Precision Oncology Market

17.1. South Korea Precision Oncology Market Overview

17.2. South Korea Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Precision Oncology Market

18.1. Taiwan Precision Oncology Market Overview

18.2. Taiwan Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Precision Oncology Market

19.1. South East Asia Precision Oncology Market Overview

19.2. South East Asia Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Precision Oncology Market

20.1. Western Europe Precision Oncology Market Overview

20.2. Western Europe Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Precision Oncology Market

21.1. UK Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Precision Oncology Market

22.1. Germany Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Precision Oncology Market

23.1. France Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Precision Oncology Market

24.1. Italy Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Precision Oncology Market

25.1. Spain Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Precision Oncology Market

26.1. Eastern Europe Precision Oncology Market Overview

26.2. Eastern Europe Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Precision Oncology Market

27.1. Russia Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Precision Oncology Market

28.1. North America Precision Oncology Market Overview

28.2. North America Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Precision Oncology Market

29.1. USA Precision Oncology Market Overview

29.2. USA Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Precision Oncology Market

30.1. Canada Precision Oncology Market Overview

30.2. Canada Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Precision Oncology Market

31.1. South America Precision Oncology Market Overview

31.2. South America Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Precision Oncology Market

32.1. Brazil Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Precision Oncology Market

33.1. Middle East Precision Oncology Market Overview

33.2. Middle East Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Precision Oncology Market

34.1. Africa Precision Oncology Market Overview

34.2. Africa Precision Oncology Market, Segmentation By Type, Segmentation By Test Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Precision Oncology Market Regulatory and Investment Landscape

36. Precision Oncology Market Competitive Landscape And Company Profiles

36.1. Precision Oncology Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Precision Oncology Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Precision Oncology Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. AstraZeneca plc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

37. Precision Oncology Market Other Major And Innovative Companies

Amgen Inc., Agilent Technologies Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, NeoGenomics Laboratories Inc., Myriad Genetics Inc., Invitae Corporation, Caris Life Sciences, Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Strata Oncology Inc.

38. Global Precision Oncology Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Precision Oncology Market

40. Precision Oncology Market High Potential Countries, Segments and Strategies

40.1 Precision Oncology Market In 2030 - Countries Offering Most New Opportunities

40.2 Precision Oncology Market In 2030 - Segments Offering Most New Opportunities

40.3 Precision Oncology Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Precision Oncology Market, Overview Of Key Products - Product Examples

Table 2: Global Precision Oncology Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Precision Oncology Market, Supply Chain Analysis

Table 4: Global Precision Oncology Market, Major Raw Material Providers

Table 5: Global Precision Oncology Market, Major Resource Providers

Table 6: Global Precision Oncology Market, Major Manufacturers (Suppliers)

Table 7: Global Precision Oncology Market, Major Distributors And Channel Partners

Table 8: Global Precision Oncology Market, Key Technologies & Future Trends

Table 9: Global Precision Oncology Market, Major Trends

Table 10: Global Precision Oncology Market, Major End Users

Table 11: Global Precision Oncology Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Precision Oncology Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Precision Oncology Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Precision Oncology Market - TAM, US$ Billion, 2025

Table 15: Global Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Precision Oncology Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Precision Oncology Market, Segmentation By End-users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Precision Oncology Market, Sub-Segmentation Of Genomic Sequencing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Precision Oncology Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Precision Oncology Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Precision Oncology Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Precision Oncology Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Precision Oncology Market - Company Scoring Matrix

Table 98: Pfizer Inc. Financial Performance

Table 99: F. Hoffmann-La Roche Ltd. Financial Performance

Table 100: Thermo Fisher Scientific Inc. Financial Performance

Table 101: AstraZeneca plc. Financial Performance

Table 102: Novartis AG Financial Performance

Table 103: Global Precision Oncology Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Precision Oncology Market, Competitive Dashboard

Table 105: Global Precision Oncology Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Precision Oncology Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 107: Global, Precision Oncology Market Size Gain ($ Billion), Segmentation By Test Type, 2025 – 2030

Table 108: Global, Precision Oncology Market Size Gain ($ Billion), Segmentation By Cancer Type, 2025 – 2030

List Of Figures

Figure 1: Global Precision Oncology Market, Overview Of Key Products - Product Examples

Figure 2: Global Precision Oncology Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Precision Oncology Market, Supply Chain Analysis

Figure 4: Global Precision Oncology Market, Major Raw Material Providers

Figure 5: Global Precision Oncology Market, Major Resource Providers

Figure 6: Global Precision Oncology Market, Major Manufacturers (Suppliers)

Figure 7: Global Precision Oncology Market, Major Distributors And Channel Partners

Figure 8: Global Precision Oncology Market, Key Technologies & Future Trends

Figure 9: Global Precision Oncology Market, Major Trends

Figure 10: Global Precision Oncology Market, Major End Users

Figure 11: Global Precision Oncology Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Precision Oncology Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Precision Oncology Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Precision Oncology Market - TAM, US$ Billion, 2025

Figure 15: Global Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Precision Oncology Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Precision Oncology Market, Segmentation By End-users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Precision Oncology Market, Sub-Segmentation Of Genomic Sequencing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Precision Oncology Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Precision Oncology Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Precision Oncology Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Precision Oncology Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Precision Oncology Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Precision Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Precision Oncology Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Precision Oncology Market - Company Scoring Matrix

Figure 98: Pfizer Inc. Financial Performance

Figure 99: F. Hoffmann-La Roche Ltd. Financial Performance

Figure 100: Thermo Fisher Scientific Inc. Financial Performance

Figure 101: AstraZeneca plc. Financial Performance

Figure 102: Novartis AG Financial Performance

Figure 103: Global Precision Oncology Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Precision Oncology Market, Competitive Dashboard

Figure 105: Global Precision Oncology Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Precision Oncology Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 107: Global, Precision Oncology Market Size Gain ($ Billion), Segmentation By Test Type, 2025 – 2030

Figure 108: Global, Precision Oncology Market Size Gain ($ Billion), Segmentation By Cancer Type, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Boiler, Tank, And Shipping Container Market Report 2026 - Global Outlook – By Equipment Type (Power Boiler And Heat Exchanger, Metal Tank (Heavy Gauge)), By Product Type (Refrigerated Container, Dry Storage Container, Sp...

Drill Pipe Market Report 2026 - Global Outlook – By Type (Standard Drill Pipes, Heavy Weight Drill Pipes, Drill Collars), By Material (Alloys, Composites, Other Materials), By Application (Offshore, Onshore) – Market Siz...

Pipeline Construction Market Report 2026 - Global Outlook – By Pipe Type (Metallic, Non-Metallic ), By Equipment (Valves, Pipeline, Metering Skids, Compressor stations ), By Operation (Transmission, Distribution), By App...

Rapid Strength Concrete Market Report 2026 - Global Outlook – By Type (Under C30, C30-C60, Above C60), By Strength (0 To 40 Megapascal (Mpa), 40 To 80 Megapascal (Mpa), Above 80 Megapascal (Mpa)), By Application (Airport...

Dry Construction Market Report 2026 - Global Outlook – By Type (Supporting Framework, Boarding), By Material (Plasterboard, Wood, Metal, Plastic), By System (Ceiling System, Wall System, Flooring System), By Application ...

Pipeline Transport Market Report 2026 - Global Outlook – By Type (Crude Oil Pipeline Transport; Natural Gas Pipeline Transport; Refined Petroleum Products Pipeline Transport; Other Types), By Solutions (Security Solution...

Precast Construction Market Report 2026 - Global Outlook – By Structure System (Beam & Column System, Floor & Roof System, Bearing Wall System), By Construction Type (Modular, Manufactured Homes), By End User (Residentia...

Frequently Asked Questions

How big is the Precision Oncology Market?

The Precision Oncology market was valued at $106.21 billion in 2025, increased to $117.67 billion in 2026, and is projected to reach $175.38 billion by 2030.

What is the Precision Oncology market growth?

The global Precision Oncology market is expected to grow at a CAGR of 10.5% from 2026 to 2035 to reach $175.38 billion by 2035.

Who are the key players in Precision Oncology market?

Some Key Players in the Precision Oncology market Include, Pfizer Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., AstraZeneca plc., Novartis AG, Amgen Inc., Agilent Technologies Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, NeoGenomics Laboratories Inc., Myriad Genetics Inc., Invitae Corporation, Caris Life Sciences, Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Strata Oncology Inc. .

What is the anticipated growth trend for the Precision Oncology market?

Major trend in this market includes: Advancing Personalized Cancer Care Through Genomic-Driven Innovations. For further insights on this market. request a sample here

Which region has the most growth potential in the Precision Oncology market?

North America was the largest region in the precision oncology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.